How often should patients be reviewed after treatment with iodine-131 for thyrotoxicosis?
- 21 October 1978
- Vol. 2 (6145) , 1115-1117
- https://doi.org/10.1136/bmj.2.6145.1115
Abstract
Six to 18 years after treatment with iodine-131 for thyrotoxicosis 69 euthyroid patients with raised serum thyrotrophin (TSH) concentrations (mean 25.0 +/- SE 2.0 mU/l) and 61 with normal concentrations (mean 4.0 +/- 0.2 mU/l) were included in a prospective five-year follow-up study beginning in 1972. During this period 13 patients from the original group with raised serum TSH concentrations became hypothyroid. In contrast it was five years before hypothyroidism developed in a single patient from the group with normal serum TSH concentrations in 1972, although raised concentrations were recorded in 19 of these patients during the study.Keywords
This publication has 6 references indexed in Scilit:
- ASYMPTOMATIC AUTOIMMUNE THYROIDITIS AND CORONARY HEART-DISEASE Cross-sectional and Prospective StudiesThe Lancet, 1977
- Premyxoedema--a cause of preventable coronary heart disease.1977
- INTENTIONAL RADIOIODINE ABLATION IN GRAVES' DISEASEThe Lancet, 1975
- THYROID FUNCTION IN THE LONG-TERM FOLLOW-UP OF PATIENTS TREATED WITH IODINE-131 FOR THYROTOXICOSISThe Lancet, 1975
- RELATION OF THYROID-STIMULATING IMMUNOGLOBULINS TO THYROID FUNCTION AND EFFECTS OF SURGERY, RADIOIODINE, AND ANTITHYROID DRUGSThe Lancet, 1975
- AN ASSESSMENT OF PLASMA TSH RADIOIMMUNOASSAY AND OF THE TSH STIMULATION TEST IN THE DIAGNOSIS OF 100 CONSECUTIVE PATIENTS WITH SUSPECTED HYPOTHYROIDISMClinical Endocrinology, 1973